These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9085149)

  • 21. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
    Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
    Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melan-A positive dermal cells in malignant melanoma in situ.
    Danga ME; Yaar R; Bhawan J
    J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripherin assembles into homopolymers in SW13 cells.
    Cui C; Stambrook PJ; Parysek LM
    J Cell Sci; 1995 Oct; 108 ( Pt 10)():3279-84. PubMed ID: 7593288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanocytic tumors with intraepidermal melanophages: a report of five cases with review of 231 archived cutaneous melanocytic tumors.
    Fujimoto M; Basko-Plluska JL; Krausz T; Selim MA; Shea CR
    J Cutan Pathol; 2015 Jun; 42(6):394-9. PubMed ID: 25733008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The histology and differential diagnosis of Spitz nevus.
    Binder SW; Asnong C; Paul E; Cochran AJ
    Semin Diagn Pathol; 1993 Feb; 10(1):36-46. PubMed ID: 8506416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes.
    Busam KJ; Sung J; Wiesner T; von Deimling A; Jungbluth A
    Am J Surg Pathol; 2013 Feb; 37(2):193-9. PubMed ID: 23026932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of stem cell markers in malignant melanoma.
    Klein WM; Wu BP; Zhao S; Wu H; Klein-Szanto AJ; Tahan SR
    Mod Pathol; 2007 Jan; 20(1):102-7. PubMed ID: 17143262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the intermediate filament peripherin in extraskeletal myxoid chondrosarcoma.
    Cummings TJ; Shea CR; Reed JA; Burchette JL; Prieto VG
    J Cutan Pathol; 2000 Mar; 27(3):141-6. PubMed ID: 10728817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell kinetics of melanocytes in common and dysplastic nevi and in primary and metastatic cutaneous melanoma.
    Urso C; Bondi R; Balzi M; Scubla E; Mauri P; Becciolini A; Tarocchi S; Vallecchi C
    Pathol Res Pract; 1992 Apr; 188(3):323-9. PubMed ID: 1625997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of intermediate filaments in conjunctival melanocytic lesions.
    Pitz S
    Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):846-50. PubMed ID: 12397434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation.
    Skelton HG; Smith KJ; Barrett TL; Lupton GP; Graham JH
    Am J Dermatopathol; 1991 Dec; 13(6):543-50. PubMed ID: 1725245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of staining for neurone specific enolase in benign and malignant melanocytic lesions of the skin.
    Dhillon AP; Rode J
    Diagn Histopathol; 1982; 5(3):169-74. PubMed ID: 6183082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
    Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
    Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spitz's nevi with halo reaction: a histopathologic study of 17 cases.
    Harvell JD; Meehan SA; LeBoit PE
    J Cutan Pathol; 1997 Nov; 24(10):611-9. PubMed ID: 9449488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
    Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
    Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.